The September 2025 update of WuXi LabNetwork’s GalaXi Space delivers a major expansion, now featuring over 25.8 billion synthesis-ready products. Built from 185 curated reactions and 30,877 high-quality building blocks, GalaXi is one of the largest tangible Chemical Spaces for modern drug discovery.
This release broadens structural diversity with novel scaffolds and sp³-rich motifs, helping early-stage teams explore with confidence and move from virtual screening to real compounds with reliable synthetic feasibility.
The GalaXi update is available to download and can be explored with BioSolveIT applications:
- infiniSee
- FTrees (fuzzy pharmacophore search)
- SpaceLight (fingerprint/Tanimoto similarity)
- SpaceMACS (substructure matching)
All results found with BioSolveIT software are tangible and can be synthesized on demand through WuXi LabNetwork, enabling a smooth path from in silico discovery to experimental validation.